Celon Pharma S.A. (WSE: CLN)
Poland flag Poland · Delayed Price · Currency is PLN
27.50
-0.10 (-0.36%)
Sep 27, 2024, 3:34 PM CET

Celon Pharma Company Description

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.

It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland.

Celon Pharma S.A. operates as a subsidiary of Glatton Sp. z o.o.

Celon Pharma S.A.
Country Poland
Founded 2002
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 515
CEO Maciej Wieczorek

Contact Details

Address:
Ogrodowa 2A
Lomianki, 05-092
Poland
Phone 48 227 51 59 33
Website celonpharma.com

Stock Details

Ticker Symbol CLN
Exchange Warsaw Stock Exchange
Fiscal Year January - December
Reporting Currency PLN
ISIN Number PLCLNPH00015
SIC Code 2834

Key Executives

Name Position
Dr. Maciej Wieczorek Ph.D. Chief Executive Officer and President of Management Board
Bartosz Szalek Chief Financial Officer and Member of the Management Board